PharmiWeb.com - Global Pharma News & Resources
27-Feb-2019

Clinical Oncology Next Generation Sequencing (NGS) Market Key Players,Analysis and Forecast 2019 to 2028

Increasing coverage of NGS coupled with improving understanding of the genetic markers of virulence and resistance provided by next generation sequencing are major factors anticipated to drive growth of the global market over the forecast period.

To get more insights, visit: https://marketresearch.biz/report/clinical-oncology-next-generation-sequencing-ngs-market/

Oncology is the study of medicines that is useful and which deals with diagnosis, treatment & prevention of cancer. Next Generation Sequencing (NGS) is alluded to as a non-Sanger based high throughput DNA sequencing innovation. The global clinical oncology next generation sequencing market report has been segmented on the basis of technology, workflow, and end user, and region.

On the basis of technology, the global market has been segmented into whole genome sequencing, targeted sequencing & resequencing, and whole exon sequencing. The metallic whole genome sequencing segment is expected to account for major share in terms of revenue in the global clinical oncology next generation sequencing market. The targeted sequencing & resequencing segment revenue is also anticipated to register highest CAGR over the forecast.

On the basis of workflow, the global market has been segmented into NGS data analysis, NGS pre-sequencing, AND NGS sequencing.

On the basis of region, the global market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

North America market is estimated to dominate with significant revenue share in the global market in 2017. The Asia Pacific market is projected to register highest CAGR in terms of revenue in the next 10 years, due to growing automation in the pre-sequencing protocols in the countries in this region.

Key players operating in the global clinical oncology next generation sequencing market include Myriad Genetics, Inc., Caris Life Sciences, Inc., Illumina, Inc., Foundation Medicine, Inc., Agilent Technologies, Genomatix Software GmbH, Bio-Rad Laboratories, GATC Biotech, Oxford Nanopore Technologies Limited, Pacific Biosciences of California, Inc., Macrogen, Inc., and PerkinElmer, Inc.

For sample copy of the report, please click:  https://marketresearch.biz/report/clinical-oncology-next-generation-sequencing-ngs-market/request-sample/

Main attractions of the market report

— Analysis of upcoming and past market information will help in structuring and outlining of current business strategies.

— A detailed information of players, their business strategies will advantageous in understanding the consumer demands and market scope.

— advancement opportunities and forecast buyer requests will immediate the collection of revenue.

— The most latest subtle elements industry revise, product launching events, production network study, growth and risk factors included which will help in speculation feasibility analysis.

Editor Details

Last Updated: 27-Feb-2019